4.6 Review

Radionuclides for Targeted Therapy: Physical Properties

Journal

MOLECULES
Volume 27, Issue 17, Pages -

Publisher

MDPI
DOI: 10.3390/molecules27175429

Keywords

radionuclide; targeted therapy; radionuclide therapy; radioactivity; molecular radiotherapy; beta; alpha; auger

Funding

  1. South-Eastern Norway Regional Health Authority [2020028]

Ask authors/readers for more resources

This review focuses on the physical characteristics of radionuclides that are relevant for radionuclide therapy, and points out that these characteristics vary considerably between different radionuclides. The selection of different characteristics should be optimized based on specific therapeutic targets, and some characteristics may be advantages for certain applications but drawbacks for others.
A search in PubMed revealed that 72 radionuclides have been considered for molecular or functional targeted radionuclide therapy. As radionuclide therapies increase in number and variations, it is important to understand the role of the radionuclide and the various characteristics that can render it either useful or useless. This review focuses on the physical characteristics of radionuclides that are relevant for radionuclide therapy, such as linear energy transfer, relative biological effectiveness, range, half-life, imaging properties, and radiation protection considerations. All these properties vary considerably between radionuclides and can be optimised for specific targets. Properties that are advantageous for some applications can sometimes be drawbacks for others; for instance, radionuclides that enable easy imaging can introduce more radiation protection concerns than others. Similarly, a long radiation range is beneficial in targets with heterogeneous uptake, but it also increases the radiation dose to tissues surrounding the target, and, hence, a shorter range is likely more beneficial with homogeneous uptake. While one cannot select a collection of characteristics as each radionuclide comes with an unchangeable set, all the 72 radionuclides investigated for therapy-and many more that have not yet been investigated-provide numerous sets to choose between.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available